Current
36.2×
5-Year Average
31.0×
All-Time High
2367.9×
All-Time Low
4.5×
P/S Ratio daily chart for SELLAS Life Sciences Group (SLS)
Jun 14, 2021 – Jun 12, 2026 · 1,256 trading days
P/S ratio is not shown for periods when TTM revenue was negative.
Historical P/S Ratio for SELLAS Life Sciences Group (SLS) from 2007 to 2025
| 2025 | $577.20M | $0.00 | — | — | |
| 2024 | $76.95M | $0.00 | — | — | |
| 2023 | $32.65M | $0.00 | — | — | |
| 2022 | $49.05M | $1.00M | 49.1× | +37.5× | |
| 2021 | $87.88M | $7.60M | 11.6× | -20.2× | |
| 2020 | $60.33M | $1.90M | 31.8× | — | |
| 2019 | $20.71M | $0.00 | — | — | |
| 2018 | $26.81M | $0.00 | — | — | |
| 2017 | $41.73M | $0.00 | — | — | |
| 2016 | $72.75M | $0.00 | — | — | |
| 2015 | $2.14B | $0.00 | — | — | |
| 2014 | $1.67B | $9.32M | 179.2× | -1906.8× | |
| 2013 | $5.19B | $2.49M | 2086.1× | +1530.0× | |
| 2012 | $1.14B | $2.06M | 556.0× | — | |
| 2011 | $202.79M | $0.00 | — | — | |
| 2010 | $575.39M | $243.00K | 2367.9× | — | |
| 2009 | $755.56M | $0.00 | — | — | |
| 2008 | $711.04M | $0.00 | — | — | |
| 2007 | $1.19B | $0.00 | — | — |
- 2025—
- 2024—
- 2023—
- 202249.1×
- 202111.6×
- 202031.8×
- 2019—
- 2018—
- 2017—
- 2016—
- 2015—
- 2014179.2×
- 20132086.1×
- 2012556.0×
- 2011—
- 20102367.9×
- 2009—
- 2008—
- 2007—
About P/S Ratio at SELLAS Life Sciences Group (SLS)
SELLAS Life Sciences Group (SLS) P/S ratio is 36.2× as of May 10, 2023. The 5-year average is 31.0×. The sector median currently stands at 3.7×. The current ratio is at the 71th percentile of its own 10-year history.
SELLAS Life Sciences Group (SLS) historical P/S ratio has ranged from a low of 4.5× (2022) to a high of 2367.9× (2010) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
SELLAS Life Sciences Group P/S Ratio by Year
SELLAS Life Sciences Group P/S Ratio 2022: 49.1×
SELLAS Life Sciences Group (SLS) P/S ratio in 2022 was 49.1×, expanded from 11.6× the prior year.
SELLAS Life Sciences Group P/S Ratio 2021: 11.6×
SELLAS Life Sciences Group (SLS) P/S ratio in 2021 was 11.6×, contracted from 31.8× the prior year.
SELLAS Life Sciences Group P/S Ratio 2020: 31.8×
SELLAS Life Sciences Group (SLS) P/S ratio in 2020 was 31.8×, contracted from 179.2× the prior year.
SELLAS Life Sciences Group P/S Ratio 2014: 179.2×
SELLAS Life Sciences Group (SLS) P/S ratio in 2014 was 179.2×, contracted from 2086.1× the prior year.
SELLAS Life Sciences Group P/S Ratio 2013: 2086.1×
SELLAS Life Sciences Group (SLS) P/S ratio in 2013 was 2086.1×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of SELLAS Life Sciences Group (SLS), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.4× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric